HF Best Ideas
AnalysesQuarterly LettersInsightsChartsWarren AI
All funds

Greystone Capital Management

Dec 2024 → Oct 2026 · Publishes quarterly · 5 funds

Our archive holds 8 letters from Greystone Capital Management, behind 24 investment theses and positions in 15 companies. Every quote below is copied verbatim from the letter it came from.

Writes about

Get an email when this fund publishes its next letter

8
Letters
15
Companies
7
Moves
24
Theses

3 strategies

Greystone Capital Management publishes a letter per strategy. Each one has its own page with what it holds, what it bought and what it wrote.

Returns as reported in each strategy’s latest letter, extracted automatically and not verified by us; one share class, in its own currency. Not investment advice. Past performance does not predict future returns.

Also filed under Greystone Capital Management, Greystone.

What they bought and sold · 7 moves

  • New positionStrata Critical Medical
    October 2026
    “During Q2 and into Q3, we built a position in Strata Critical Medical, an organ transplant and logistics business that has been left for dead given its microcap status, prior history as a failed SPAC, strategy shift and shareholder turnover.”
    Read the letter
  • AddedShift4 Technologies
    June 2026
    “I’ve been adding to our position.”
    Read the letter
  • AddedKits Eyecare
    June 2026
    “I’ve been adding to our position as the thesis plays out and expect another strong year during 2026 and 2027 as KITS glasses business continues to grow and as they expand into new geographies and reach new customers.”
    Read the letter
  • AddedPitney Bowes
    June 2026
    “This is the first time I’ve written about our investment in Pitney Bowes, which we started purchasing in 2025 and have continued adding through volatility.”
    Read the letter
  • ExitedBel Fuse
    September 2025
    “During the quarter, we sold out of our position in Bel Fuse to allocate to higher forward IRR opportunities, as the stock exceeded our estimate of intrinsic value.”
    Read the letter
  • TrimmedSylogist
    September 2025
    “As a result, I reduced our position as I no longer feel Sylogist meets the requirement for a top five holding, where it’s been for over three years.”
    Read the letter
  • AddedKITS Eyecare
    June 2025
    “KITS Eyecare (KITS.TO) I outlined KITS as a new investment in our Q1 letter, so I will keep my comments brief.”
    Read the letter

Companies held · 15

Every company Greystone Capital Management has disclosed a position in across our archive, with the letter that last mentioned it.

Theses · 24

  • KITS Eyecare Ltd.
    October 2026

    KITS Eyecare is a fast-growing, customer-focused eyecare business whose strong culture and track record support confidence through a co-founder transition, making it a potentially exceptional long-term holding.

    Read the full thesis
  • Strata Critical Medical, Inc.
    October 2026

    Strata Critical Medical is a device-agnostic, full-service organ transplant logistics and clinical services provider with structural tailwinds, a density flywheel, and an accretive M&A roll-up strategy that could drive significant EBITDA growth and margin expansion from a depressed valuation.

    Read the full thesis
  • Limbach
    June 2026

    Limbach has an overlooked asset-light recurring service business inside a misunderstood mechanical contractor label, with faster growth and higher margins than the consolidated GAAP numbers imply.

    Read the full thesis
  • APi Group
    June 2026

    APi Group is a durable business whose mix shift toward recurring inspection and monitoring work increases margins, cash flow, and reduces cyclicality.

    Read the full thesis
  • Secure Waste Infrastructure
    June 2026

    Secure Waste Infrastructure was misread as a low-margin commodity business even though its permitted waste facilities function as regional monopolies.

    Read the full thesis
  • Pitney Bowes
    June 2026

    Pitney Bowes is a neglected but durable installed-base and presort business with pricing power, strong capital allocation, and multiple re-rating potential.

    Read the full thesis
  • Kits Eyecare
    June 2026

    Kits Eyecare has a hard-to-replicate price and convenience moat, improving customer behavior, and a long growth runway.

    Read the full thesis
  • Shift4 Technologies
    June 2026

    Shift4 Technologies has integrated payments exposure, differentiated software, strong cash conversion, and potential upside if execution and valuation normalize.

    Read the full thesis
  • Medical Facilities Corp.
    March 2026

    Medical Facilities Corp. operates specialty hospitals with durable demand and management-driven buybacks that have steadily increased per-share value.

    Read the full thesis
  • KITS Eyecare
    December 2025

    KITS Eyecare is a vertically integrated DTC eyecare company with strong unit economics, rapid organic growth, and structural advantages that support high-rate free cash flow compounding.

    Read the full thesis
  • Natural Resource Partners
    December 2025

    Natural Resource Partners is a coal royalty and infrastructure business with durable low-capex cash flows, a strengthening balance sheet, and shares trading at a substantial discount to intrinsic value.

    Read the full thesis
  • Shift4 Payments
    December 2025

    Shift4 Payments is an integrated end-to-end payments platform with low churn, strong unit economics, founder-led alignment, and a compelling valuation supported by merchant conversion, M&A, and buybacks.

    Read the full thesis

Letter archive · 8

2026

2025

2024

Get Greystone Capital Management’s next letter the day it lands

We track Greystone Capital Management alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans→
Share this fund